Jiang Yixin, Lee Junghan, Seo Jin-Myung, Davaa Enkhzaya, Shin Kyung-Ju, Yang Su-Geun
Department of Biomedical Science, BK21 FOUR Program in Biomedical Science and Engineering, Inha University College of Medicine, B-308, Chungsuk Bldg, 366, Seohae-Daero, Jung-Gu, Incheon, 22212, Republic of Korea.
Inha Institute of Aerospace Medicine, Inha University College of Medicine, Incheon, 22332, Republic of Korea.
Biomater Res. 2022 Mar 7;26(1):8. doi: 10.1186/s40824-022-00255-9.
BACKGROUND: Superparamagnetic iron oxide nanoparticles (SPIO) have been applied for decades to design theranostic polymeric micelles for targeted cancer therapy and diagnostic MR imaging. However, the effects of SPIO on the physicochemical, and biological properties of polymeric micelles have not yet been fully elucidated. Therefore, we investigated potential effect of SPIO on the physical and biological properties of theranostic polymeric micelles using representative cancer drug (doxorubicin; Doxo) and polymer carrier (i.e., poly (ethylene glycol)-co-poly(D,L-lactide), PEG-PLA). METHODS: SPIO were synthesized from Fe(acetyl acetonate) in an aryl ether. SPIO and Doxo were loaded into the polymeric micelles by a solvent-evaporation method. We observed the effect of SPIO-clustering on drug loading, micelle size, thermodynamic stability, and theranostic property of PEG-PLA polymeric micelles. In addition, cellular uptake behaviors, pharmacokinetic and biodistribution study were performed. RESULTS: SPIO formed hydrophobic geometric cavity in the micelle core and significantly affected the integrity of micelles in terms of micelle size, Doxo loading, critical micelle concentration (CMC) and in vitro dissociation. In vivo pharmacokinetic studies also showed the enhanced Area Under Curve (AUC) and elongated the half-life of Doxo. CONCLUSIONS: Clustered SPIO in micelles largely affects not only MR imaging properties but also biological and physical properties of polymeric micelles.
J Microencapsul. 2012-11-27
MedComm (2020). 2024-10-20
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024
Technol Cancer Res Treat. 2023
Acta Biomater. 2020-1-15
Nanotechnology. 2019-9-6
Nanomedicine (Lond). 2019-6-19
ACS Appl Mater Interfaces. 2017-10-4